We are Sorry, This Page doesn't Exist

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Gilead (GILD) enters into a strategic collaboration with Precision BioSciences for developin.....»»

Precision BioSciences (NASDAQ: DTIL) shares are trading higher after the company reported its ARCUS platform showed a promising gene editing approach for transthyretin amyloidosis. read more.....»»

read more.....»»

Vertex Pharmaceuticals Inc. said Tuesday it plans to pay $1.1 billion to Crispr Therapeutics AG as part of a deal to test an experimental gene-editing therapy for sickle cell disease and transfusion-dependent beta-tha.....»»

Entercom Communications Corp. has reached a long-term licensing agreement to perform all of the hit songs from songwriters and publishers represented by performance rights organization Global Music Rights (GMR). GMR was created in 2013 by music mogu.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

NASCAR Hall of Famer Richard Petty has reached a partnership deal with CSE, an Atlanta-based talent agency. The agency announced on Wednesday that it will be leading marketing and licensing efforts for Petty, the Level Cross native who won more than 2.....»»

CSE has reached a partnership deal with NASCAR Hall of Famer Richard Petty. The Atlanta-based talent agency announced on Wednesday that it will be leading marketing and licensing efforts for Petty, who is considered by many as the king of stock car rac.....»»

Here's a roundup of top developments in the .....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Here's a roundup of top developments in the biotech space over the .....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Aro Biotherapeutics could get up to $1.4 billion as part of a new licensing deal it has entered into with a California pharmaceutical company. Ionis Pharmaceuticals will use Philadelphia-based Aro Biotherapeutics' Centyrin technology to develop targ.....»»

Aro Biotherapeutics could get up to $1.4 billion as part of a new licensing deal it has entered into with a California pharmaceutical company. Ionis Pharmaceuticals will use Philadelphia-based Aro Biotherapeutics' Centyrin technology to develop targ.....»»

A gene therapy invented at Nationwide Children's Hospital just landed a licensing deal worth as much as $2.8 billion for a Boston biotech, and now the company's Columbus office will play a big role in getting the treatment to the market. Sarepta Th.....»»

Sarepta Therapeutics shares made a handy gain to start the week after it announced a licensing agreement with Roche for its investigational gene therapy for Duchenne muscular dystrophy......»»

Roche Holding AG made its second major gene therapy deal in a year on Monday, spending $1.15 billion to obtain the rights to Sarepta Therapeutics Inc's investigational drug to treat duchenne muscular dystrophy (DMD) outside the United States......»»

Roche entered into a $1.15 billion licensing agreement with Sarepta Therapeutics to obtain the right to launch and commercialize Sarepta's investigational gene therapy for Duchenne muscular dystrophy (DMD) outside the United States......»»